CNBC -- critique. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Pastimes : CNBC -- critique.

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: capitalistbeatnik who started this subject	1/3/2001 9:57:10 AM
From: scaram(o)uche	Read Replies (1) of 17683

Bill G.: If you're going to do this "popup" jazz, try popping up when Tommy talks about ^BTK from the NAZ wall. Teach him what ^BTK is, that it's an average of mostly OPERATIONAL companies, not research boutiques. These companies produce DRUGS, and are therefore relatively recession-strong. The index does NOT represent the biotech sector as a whole; the biotech bubble has ALREADY popped. CNBC's commentary on the sector is beginning to tick biotech champions off, big-time. BFD, you say? Look for CRIS (Stryker) and Centocor (JNJ) news from yesterday. While Tommy is misrepresenting the ^BTK, biotech garnered two positive results from regulatory agencies. The sector is hot, even if CNBC is lending their ear to those who would misrepresent its current status. Message 15110089 Message 15110220 Stop misrepresenting the relative strength of the biotech sector. Start to understand that the sector was "charged" last year, and that the pipelines address recession-resistant markets. Thanks in advance. Richard C. Harmon, Ph.D.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next